We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Sareum Announces Collaboration with Schering

Sareum Announces Collaboration with Schering

Sareum Announces Collaboration with Schering

Sareum Announces Collaboration with Schering

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Sareum Announces Collaboration with Schering"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sareum Holdings plc has announced that it has entered into a collaborative agreement with Schering AG, Germany.

The aim of the collaboration is for Sareum to provide protein structure determination capabilities to accelerate drug discovery research at Schering.

Sareum will utilise its expertise in high throughput protein expression, purification and structure determination to demonstrate how Schering’s potential drug candidates interact with their target protein receptor.

In return, Sareum will receive research fees and success milestone payments.

Commenting on the agreement, Sareum’s Chief Executive Officer, Dr Tim Mitchell, said, "We are delighted that Schering has chosen Sareum as their partner in protein structure determination."

"This is a further important collaboration that Sareum has signed with a major international pharmaceutical company."

"Revenues generated in collaborations such as this are valuable sources of financial support for our in-house cancer research programs."

"We look forward to successful delivery of this project to Schering and to closing additional partnerships such as this."